advertisement
Rejdak R 25
Showing records 1 to 25 | Display all abstracts from Rejdak R90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Fiedorowicz M
Frontiers in pharmacology 2020; 11: 573238
90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Stahnke T
Royal Society open science 2020; 7: 200441
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Posarelli C
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Wełniak-Kamińska M
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Toro MD
Journal of clinical medicine 2020; 9:
90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Gajda-Deryło B
Royal Society open science 2020; 7: 200441
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Świątkiewicz M
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Rejdak R
Journal of clinical medicine 2020; 9:
90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Jünemann AG
Royal Society open science 2020; 7: 200441
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Żarnowski T
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Orzeł J
Frontiers in pharmacology 2020; 11: 573238
90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Stachs O; Sterenczak KA
Royal Society open science 2020; 7: 200441
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Chorągiewicz T
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Pożarowska D
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Toro MD
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Longo A
Journal of clinical medicine 2020; 9:
90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Rejdak R; Beck J
Royal Society open science 2020; 7: 200441
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Miccoli M
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Rejdak R
Frontiers in pharmacology 2020; 11: 573238
90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Schütz E
Royal Society open science 2020; 7: 200441
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Bogorodzki P
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Nardi M
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Grieb P
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Figus M
Journal of clinical medicine 2020; 9:
90781 Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts
Möller S; Barrantes I; Warsow G; Struckmann S; Fuellen G
Royal Society open science 2020; 7: 200441
